2-amino-4-[[1-[[6-(2-amino-2-oxoethyl)-3-[[4,6-dihydroxy-2-methyl-8-oxo-8-[(11,19,27,35-tetraamino-3-hydroxytetracontyl)amino]octan-3-yl]carbamoyl]-2-methyl-5,8,11-trioxo-1,4,7-triazacycloundec-9-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
| Internal ID | ca278c1a-531b-4761-911f-e168b3ad2a92 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | 2-amino-4-[[1-[[6-(2-amino-2-oxoethyl)-3-[[4,6-dihydroxy-2-methyl-8-oxo-8-[(11,19,27,35-tetraamino-3-hydroxytetracontyl)amino]octan-3-yl]carbamoyl]-2-methyl-5,8,11-trioxo-1,4,7-triazacycloundec-9-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C71H133N15O13/c1-5-6-19-28-49(72)29-20-11-7-12-21-30-50(73)31-22-13-8-14-23-32-51(74)33-24-15-9-16-25-34-52(75)35-26-17-10-18-27-36-54(87)37-38-79-62(91)41-55(88)40-60(89)65(47(2)3)85-70(97)66-48(4)81-64(93)44-59(68(95)83-58(43-61(77)90)69(96)86-66)84-67(94)57(39-53-45-78-46-80-53)82-63(92)42-56(76)71(98)99/h45-52,54-60,65-66,87-89H,5-44,72-76H2,1-4H3,(H2,77,90)(H,78,80)(H,79,91)(H,81,93)(H,82,92)(H,83,95)(H,84,94)(H,85,97)(H,86,96)(H,98,99) |
| InChI Key | YSKPBPMQZLMBEW-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C71H133N15O13 |
| Molecular Weight | 1404.90 g/mol |
| Exact Mass | 1404.02072936 g/mol |
| Topological Polar Surface Area (TPSA) | 504.00 Ų |
| XlogP | 2.40 |
| Atomic LogP (AlogP) | 3.80 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 18 |
| Rotatable Bonds | 57 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8712 | 87.12% |
| Caco-2 | - | 0.8589 | 85.89% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.7571 | 75.71% |
| Subcellular localzation | Mitochondria | 0.4101 | 41.01% |
| OATP2B1 inhibitior | - | 0.8600 | 86.00% |
| OATP1B1 inhibitior | + | 0.8062 | 80.62% |
| OATP1B3 inhibitior | + | 0.9164 | 91.64% |
| MATE1 inhibitior | - | 0.8809 | 88.09% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9090 | 90.90% |
| P-glycoprotein inhibitior | + | 0.7403 | 74.03% |
| P-glycoprotein substrate | + | 0.8763 | 87.63% |
| CYP3A4 substrate | + | 0.7281 | 72.81% |
| CYP2C9 substrate | - | 0.5983 | 59.83% |
| CYP2D6 substrate | - | 0.8325 | 83.25% |
| CYP3A4 inhibition | - | 0.7310 | 73.10% |
| CYP2C9 inhibition | - | 0.9121 | 91.21% |
| CYP2C19 inhibition | - | 0.9000 | 90.00% |
| CYP2D6 inhibition | - | 0.9231 | 92.31% |
| CYP1A2 inhibition | - | 0.9109 | 91.09% |
| CYP2C8 inhibition | + | 0.7777 | 77.77% |
| CYP inhibitory promiscuity | - | 0.9336 | 93.36% |
| UGT catelyzed | - | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6264 | 62.64% |
| Eye corrosion | - | 0.9877 | 98.77% |
| Eye irritation | - | 0.8969 | 89.69% |
| Skin irritation | - | 0.7858 | 78.58% |
| Skin corrosion | - | 0.9291 | 92.91% |
| Ames mutagenesis | - | 0.5600 | 56.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3922 | 39.22% |
| Micronuclear | + | 0.7200 | 72.00% |
| Hepatotoxicity | - | 0.5125 | 51.25% |
| skin sensitisation | - | 0.8632 | 86.32% |
| Respiratory toxicity | + | 0.7889 | 78.89% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.8000 | 80.00% |
| Nephrotoxicity | - | 0.8030 | 80.30% |
| Acute Oral Toxicity (c) | III | 0.6463 | 64.63% |
| Estrogen receptor binding | + | 0.7228 | 72.28% |
| Androgen receptor binding | + | 0.7149 | 71.49% |
| Thyroid receptor binding | + | 0.5770 | 57.70% |
| Glucocorticoid receptor binding | + | 0.6025 | 60.25% |
| Aromatase binding | + | 0.7004 | 70.04% |
| PPAR gamma | + | 0.7416 | 74.16% |
| Honey bee toxicity | - | 0.7093 | 70.93% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | + | 0.5449 | 54.49% |
| Fish aquatic toxicity | + | 0.7125 | 71.25% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.88% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.73% | 83.82% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.34% | 97.23% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.30% | 96.09% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 98.20% | 94.55% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 98.13% | 90.24% |
| CHEMBL4801 | P29466 | Caspase-1 | 96.91% | 96.85% |
| CHEMBL236 | P41143 | Delta opioid receptor | 96.61% | 99.35% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.27% | 99.17% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 96.09% | 90.08% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.08% | 88.42% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.96% | 91.11% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 95.57% | 90.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 95.49% | 97.64% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 95.25% | 90.20% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 95.18% | 96.90% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 94.68% | 93.56% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 94.07% | 92.29% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 92.73% | 95.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 92.27% | 98.33% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 91.99% | 97.25% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.63% | 100.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 91.60% | 94.45% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.40% | 96.47% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 91.15% | 93.03% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.38% | 97.09% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 89.07% | 100.00% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 88.60% | 95.56% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 88.58% | 89.34% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 88.10% | 98.59% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 87.73% | 97.29% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 87.54% | 99.23% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 87.15% | 98.05% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 86.50% | 90.17% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 85.94% | 94.66% |
| CHEMBL5028 | O14672 | ADAM10 | 85.60% | 97.50% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 84.87% | 98.94% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 84.43% | 91.38% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.69% | 93.00% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.51% | 100.00% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 83.47% | 97.33% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 83.19% | 89.50% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 82.61% | 89.33% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 82.28% | 96.33% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 81.84% | 96.00% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.43% | 88.56% |
| CHEMBL2327 | P21452 | Neurokinin 2 receptor | 81.36% | 98.89% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 81.22% | 98.24% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 80.63% | 100.00% |
| CHEMBL2535 | P11166 | Glucose transporter | 80.59% | 98.75% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 80.40% | 89.00% |
| CHEMBL1628481 | P35414 | Apelin receptor | 80.37% | 97.89% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 80.17% | 91.81% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146684681 |
| LOTUS | LTS0174151 |
| wikiData | Q105359791 |